Document text
Principal Investigator: Matthew Blake Greenblatt
Organization: WEILL MEDICAL COLL OF CORNELL UNIV
Fiscal Year: 2024
Award: $361,713
Funding agency: National Institute of Arthritis and Musculoskeletal and Skin Diseases
Project Summary/Abstract
Recent work establishes that skeletal blood vessels are not just mere channels for blood, but
instead play an active role in supporting bone formation. However, it is unknown which types of
blood vessels provide this support, how these blood vessels alter the production of bone
forming cells from their stem cell progenitors, or how this coupling between blood vessels and
bone forming cells is tied to the overall physiologic demand for bone formation. Progress in this
area has been impeded by most of the growth factors for blood vessels in bone also having
direct effects on bone forming cells, preventing their use to study interactions between blood
vessels and bone forming cells. We have recently identified a new growth factor for skeletal
blood vessels, SLIT3. SLIT3 is produced by bone forming cells and increases bone formation
not by targeting bone forming cells themselves, but instead by promoting outgrowth of blood
vessels that in turn support bone formation. Thus, SLIT3 presents an attractive tool to study
which blood vessels in bone influence bone formation and how these blood vessels shape the
production of bone forming cells. Furthermore, recent advances in understanding skeletal stem
cells from ourselves and others identify that bone contains multiple populations of stem cells
giving rise to bone forming cells, with each of these stem cells having a different anatomic
location and function. It is unlikely that a single type of blood vessel is able to support all of
these different of skeletal stem cell populations, and we accordingly hypothesize that different
types of skeletal blood vessels each support different types of skeletal stem cells. Here, SLIT3
to both address this hypothesis and establish fundamental paradigms for how endothelial cells
support bone formation. In Aim 1, we will study how SLIT3-mediated outgrowth of skeletal blood
vessels is driven by signals known to promote bone formation, determining if this SLIT3-driven
blood vessel outgrowth is needed for the bone formation response to these signals and also
which subsets of bone forming cells are the key producers of SLIT3 needed for these
responses. In Aim 2, we will determine which specific bone forming cells are supported by each
blood vessel type induced by SLIT3. In Aim 3, we will determine how SLIT3-induced blood
vessels shape the differentiation of bone forming cells. Overall, this work will provide a
foundation for the development of drugs targeting skeletal blood vessels as a new approach to
treat osteoporosis and other skeletal disorders.
!
Terms: <Address><Adopted><Anatomic Sites><Anatomic structures><Anatomy><Angiogenesis Factor><Angiogenic Factor><Area><Automobile Driving><Blood><Blood Reticuloendothelial System><Blood Vessels><Bone Formation><Categories><Cell Body><Cell Communication><Cell Communication and Signaling><Cell Interaction><Cell Lineage><Cell Signaling><Cell-to-Cell Interaction><Cells><Clinical><Co-culture><Cocultivation><Coculture><Coculture Techniques><Complement><Complement Proteins><Coupling><Discontinuous Capillary><Drug Targeting><Endothelial Cells><Endothelium><Foundations><Fracture Healing><Growth Agents><Growth Factor><Growth Substances><Intracellular Communication and Signaling><LEPR><LEPR gene><Location><Mediating><Mesenchymal><Mesenchymal Progenitor Cell><Mesenchymal Stem Cells><Mesenchymal progenitor><Mesenchymal stromal/stem cells><Mesenchymas><Mesenchyme><Metabolic Bone Diseases><Modeling><Morphology><Osteoblasts><Osteoclasts><Osteogenesis><Osteoporosis><Pathway interactions><Perimenopausal Bone Loss><Phenotype><Physiologic><Physiological><Play><Population><Post-Menopausal Osteoporosis><Postmenopausal Bone Loss><Postmenopausal Osteoporosis><Production><Progenitor Cells><Proteins Growth Factors><Receptor Protein><Regulation><Reporting><Role><Shapes><Signal Induction><Signal Transduction><Signal Transduction Systems><Signaling><Sinusoid><Sinusoidal Capillary><Source><Stimulus><Structure><Supporting Cell><Testing><Therapeutic><Transplantation><Vascular Endothelial Cell><Vascular Endothelium><Work><angiogenesis><arteriole><biological signal transduction><bone><bone fracture healing><bone fracture repair><bone growth factor><bone loss><bone metabolism disorder><bone tissue formation><cell type><cellular targeting><complementation><driving><drug development><fracture repair><macrophage-derived osteoblast growth factor><mesenchymal stromal progenitor cells><mesenchymal-derived stem cells><metabolic bone disease><metabolic bone disorder><mouse model><murine model><new approaches><new growth><novel><novel approaches><novel strategies><novel strategy><pathway><prevent><preventing><progenitor><progenitor cell population><progenitor population><receptor><response><skeletal><skeletal disease><skeletal disorder><skeletal growth factor><skeletal progenitor><skeletal progenitor cell><skeletal stem cell><social role><stem and progenitor cell population><stem cell population><stem cells><therapeutic candidate><tool><transplant><vascular>